IP Library Granted Patent US 8,880,186
Granted Patent B2
US 8,880,186 · App. 13/861,178 · Granted Nov 4, 2014

Renal neuromodulation for treatment of patients with chronic heart failure

Inventors: Howard R. Levin (Teaneck, NJ); Mark Gelfand (New York, NY)
Assignee: Medtronic Ardian Luxembourg S.a.r.l.
A61B18/1492A61N1/3627A61M2210/1082A61N1/36007A61N1/36114A61N1/326A61N1/05A61M5/1723A61M5/142A61N1/0551A61M5/14276A61N5/00A61N1/36117
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,880,186
App. No.
13/861,178
Granted
Nov 4, 2014
Kind
B2
Abstract

A method and apparatus for treatment of heart failure, hypertension and renal failure by stimulating the renal nerve. The goal of therapy is to reduce sympathetic activity of the renal nerve. Therapy is accomplished by at least partially blocking the nerve with drug infusion or electrostimulation. Apparatus can be permanently implanted or catheter based.

Claims (34)

1. A method comprising:

sensing a physiologic parameter of a human patient diagnosed with chronic heart failure;

generating a stimulation signal based, at least in part, on the sensed physiological parameter; and

delivering the stimulation signal from an electrical stimulator to a nerve that provides neural control of a function of a kidney of the patient, the signal causing a decrease in renal sympathetic activity of the patient,

wherein decreasing renal sympathetic nerve activity results in a therapeutically beneficial reduction in clinical symptoms of chronic heart failure in the patient.

2. The method of claim 1 wherein sensing the physiological parameter comprises sensing a physiological parameter indicative of sympathetic activity within the patient, the method further comprising identifying an increase in sympathetic activity based on the physiological parameter, and wherein generating the stimulation signal comprises generating the stimulation signal in response to the increase in sympathetic activity.

3. The method of claim 1 wherein generating the stimulation signal includes generating the stimulation signal with an implantable electrode, and delivering the stimulation signal includes delivering the stimulation signal from the implantable electrode.

4. The method of claim 1 , further comprising transmitting information regarding the physiological parameter to an external device outside of the patient.

5. The method of claim 1 wherein the physiological parameter comprises at least one of blood pressure and blood oxygen saturation.

6. A system comprising:

a sensor configured to sense a physiological parameter of a human patient diagnosed with chronic heart failure; and

an electrical stimulator configured to communicate with the sensor, wherein the electrical stimulator comprises a stimulation generator for generating a stimulation signal based on a physiological parameter sensed by the sensor and for delivering the stimulation signal to block or inhibit neural traffic along a nerve that provides neural control of a function of a kidney of the patient,

wherein blocking or inhibiting neural traffic results in a therapeutically beneficial reduction in clinical symptoms of chronic heart failure in the patient.

7. The system of claim 6 wherein the physiological parameter is indicative of sympathetic activity within the patient, and wherein the system further comprises a processor configured to identify an increase in sympathetic activity based on the physiological parameter and controls the electrical stimulator to generate the stimulation signal in response to the increase in sympathetic activity.

8. The system of claim 6 , further comprising an external device configured to receive information regarding the physiological parameter.

9. The system of claim 8 wherein the information comprises information regarding at least one of blood pressure and blood oxygen saturation.

10. A method comprising:

sensing a physiological parameter indicative of sympathetic activity within a human patient diagnosed with chronic heart failure;

identifying an increase in sympathetic activity based on the physiological parameter; and

delivering a stimulation signal to reduce neural traffic along a nerve to the identified increased in sympathetic activity,

wherein reducing traffic results in a therapeutically beneficial reduction in clinical symptoms of chronic heart failure in the patient.

11. The method of claim 10 wherein the physiological parameter is indicative of renal activity.

12. The method of claim 10 wherein the physiological parameter comprises at least one of blood pressure and blood oxygen saturation.

13. The method of claim 10 wherein sensing the physiological parameter comprises sensing a first physiological parameter, and wherein the method further comprises sensing a second physiological parameter when the first physiological parameter indicates the increase in sympathetic activity, and further wherein identifying the increase in sympathetic activity is based on the first and second physiological parameters.

14. The method of claim 10 , further comprising transmitting information regarding the physiological parameter to an external device outside of the patient.

15. A system comprising:

a sensor configured to sense a physiological parameter indicative of sympathetic activity within a human patient diagnosed with chronic heart failure;

a processor electronically coupled to the sensor and configured to identify an increase in sympathetic activity based on the physiological parameter; and

an electrical stimulator electrically coupled to the processor and configured to deliver a stimulation signal to a nerve that provides neural control of a function of a kidney of the patient, the stimulation signal being adapted to inhibit neural communication along the nerve in response to the increase in sympathetic activity,

wherein inhibiting neural communication results in a therapeutically beneficial reduction in clinical symptoms of chronic heart failure in the patient.

16. The system of claim 15 , wherein the processor comprises a processor of the electrical stimulator.

17. The system of claim 15 , further comprising a lead, wherein the electrical stimulator delivers the stimulation signal to the nerve via one or more electrodes carried by the lead.

18. The system of claim 15 wherein the physiological parameter is indicative of renal activity.

19. The system of claim 15 wherein the physiological parameter comprises at least one of blood pressure and blood oxygen saturation.

Continuity (8)
Continuation 13361019 · Jan 30, 2012
Continuation 11688178 · Mar 19, 2007
Continuation 11144173 · Jun 3, 2005
Continuation 10408665 · Apr 8, 2003
Provisional Application 60370190 · Apr 8, 2002
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60442970 · Jan 29, 2003
Related Publication 20130253603A1 · Sep 26, 2013